208 related articles for article (PubMed ID: 20720564)
1. Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNλ) in cutaneous lupus erythematosus.
Zahn S; Rehkämper C; Kümmerer BM; Ferring-Schmidt S; Bieber T; Tüting T; Wenzel J
J Invest Dermatol; 2011 Jan; 131(1):133-40. PubMed ID: 20720564
[TBL] [Abstract][Full Text] [Related]
2. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
[TBL] [Abstract][Full Text] [Related]
3. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets.
Wenzel J; Zahn S; Mikus S; Wiechert A; Bieber T; Tüting T
Br J Dermatol; 2007 Oct; 157(4):752-7. PubMed ID: 17714558
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of guanylate binding protein-1 in lesional skin of patients with cutaneous lupus erythematosus.
Naschberger E; Wenzel J; Kretz CC; Herrmann M; Stürzl M; Kuhn A
Exp Dermatol; 2011 Feb; 20(2):102-6. PubMed ID: 21121962
[TBL] [Abstract][Full Text] [Related]
5. The role of cytokines in the pathogenesis of cutaneous lupus erythematosus.
Robinson ES; Werth VP
Cytokine; 2015 Jun; 73(2):326-34. PubMed ID: 25767072
[TBL] [Abstract][Full Text] [Related]
6. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa.
Sarkar MK; Hile GA; Tsoi LC; Xing X; Liu J; Liang Y; Berthier CC; Swindell WR; Patrick MT; Shao S; Tsou PS; Uppala R; Beamer MA; Srivastava A; Bielas SL; Harms PW; Getsios S; Elder JT; Voorhees JJ; Gudjonsson JE; Kahlenberg JM
Ann Rheum Dis; 2018 Nov; 77(11):1653-1664. PubMed ID: 30021804
[TBL] [Abstract][Full Text] [Related]
7. Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches.
Wenzel J; Tüting T
Exp Dermatol; 2007 May; 16(5):454-63. PubMed ID: 17437489
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosus.
Wang D; Drenker M; Eiz-Vesper B; Werfel T; Wittmann M
Arthritis Rheum; 2008 Oct; 58(10):3205-15. PubMed ID: 18821674
[TBL] [Abstract][Full Text] [Related]
9. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis.
Wenzel J; Schmidt R; Proelss J; Zahn S; Bieber T; Tüting T
Clin Exp Dermatol; 2006 Jul; 31(4):576-82. PubMed ID: 16716166
[TBL] [Abstract][Full Text] [Related]
10. Immunostimulatory Endogenous Nucleic Acids Drive the Lesional Inflammation in Cutaneous Lupus Erythematosus.
Scholtissek B; Zahn S; Maier J; Klaeschen S; Braegelmann C; Hoelzel M; Bieber T; Barchet W; Wenzel J
J Invest Dermatol; 2017 Jul; 137(7):1484-1492. PubMed ID: 28351661
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 70 potentiates interferon alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis.
Jacquemin C; Rambert J; Guillet S; Thiolat D; Boukhedouni N; Doutre MS; Darrigade AS; Ezzedine K; Blanco P; Taieb A; Boniface K; Seneschal J
Br J Dermatol; 2017 Nov; 177(5):1367-1375. PubMed ID: 28380264
[TBL] [Abstract][Full Text] [Related]
12. Interferon-α stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus.
Zahn S; Rehkämper C; Ferring-Schmitt S; Bieber T; Tüting T; Wenzel J
Br J Dermatol; 2011 Nov; 165(5):1118-23. PubMed ID: 21711324
[TBL] [Abstract][Full Text] [Related]
13. CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.
Wenzel J; Lucas S; Zahn S; Mikus S; Metze D; Ständer S; von Stebut E; Hillen U; Bieber T; Tüting T
J Am Acad Dermatol; 2008 Mar; 58(3):437-42. PubMed ID: 18280341
[TBL] [Abstract][Full Text] [Related]
14. Lupus Skin Is Primed for IL-6 Inflammatory Responses through a Keratinocyte-Mediated Autocrine Type I Interferon Loop.
Stannard JN; Reed TJ; Myers E; Lowe L; Sarkar MK; Xing X; Gudjonsson JE; Kahlenberg JM
J Invest Dermatol; 2017 Jan; 137(1):115-122. PubMed ID: 27646883
[TBL] [Abstract][Full Text] [Related]
15. Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review.
Kuhn A; Wenzel J; Weyd H
Clin Rev Allergy Immunol; 2014 Oct; 47(2):148-62. PubMed ID: 24420508
[TBL] [Abstract][Full Text] [Related]
16. Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.
Fetter T; Smith P; Guel T; Braegelmann C; Bieber T; Wenzel J
Front Immunol; 2020; 11():344. PubMed ID: 32194562
[TBL] [Abstract][Full Text] [Related]
17. Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus.
Wenzel J; Zahn S; Bieber T; Tüting T
Arch Dermatol Res; 2009 Jan; 301(1):83-6. PubMed ID: 18784932
[TBL] [Abstract][Full Text] [Related]
18. The pathogenesis of cutaneous lupus erythematosus: The aberrant distribution and function of different cell types in skin lesions.
Zhou X; Yan J; Lu Q; Zhou H; Fan L
Scand J Immunol; 2021 Jan; 93(1):e12933. PubMed ID: 32654170
[TBL] [Abstract][Full Text] [Related]
19. Type I Immune Response Induces Keratinocyte Necroptosis and Is Associated with Interface Dermatitis.
Lauffer F; Jargosch M; Krause L; Garzorz-Stark N; Franz R; Roenneberg S; Böhner A; Mueller NS; Theis FJ; Schmidt-Weber CB; Biedermann T; Eyerich S; Eyerich K
J Invest Dermatol; 2018 Aug; 138(8):1785-1794. PubMed ID: 29526761
[TBL] [Abstract][Full Text] [Related]
20. Enhanced CCR5+/CCR3+ T helper cell ratio in patients with active cutaneous lupus erythematosus.
Freutel S; Gaffal E; Zahn S; Bieber T; Tüting T; Wenzel J
Lupus; 2011 Oct; 20(12):1300-4. PubMed ID: 21844117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
